MMP9 and cancer: Results of studies in small samples of cancer patients have been inconsistent, but higher circulating MMP-9 and TIMP-1 levels have indicated worse prognosis in studies of several cancer types.[14], [15], [16], [17] No previous studies have reported associations of levels of matrix biomarkers to cancer incidence.